Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 2 (A) Kaplan-Meier curve depicting time to death + rehospitalization. (B) Kaplan-Meier curve depicting time to death, recurrent hospitalization, unscheduled visit for heart failure,  50% increase in oral diuretic therapy, addition of new oral diuretic therapy excluding spironolactone, or any intravenous therapy with diuretics, inotropes, inodilators, or other vasoactive agents within 60 days post-randomization. Solid lines = predischarge carvedilol initiation group; dashed lines = physician-discretion postdischarge initiation group. HR = hazard ratio.
|
